 | | Vol. 14.39 – 6 October, 2022 |
| |
|
|
|
A vitality-enhanced dual-modal tracking system was designed to improve engraftment efficiency and was utilized to noninvasively explore the fate of intravenous transplanted human umbilical cord-derived MSCs during long-term treatment of ischemic stroke.
[Small] |
|  | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Biocompatibility experiments showed that Wharton’s jelly MSCs (WJMSCs) embedded in Hydroactive® Gel did not influence the cell viability, survival, proliferation, and apoptosis of WJMSCs in vitro.
[Journal of Materials Chemistry B] |
|
|
|
| Investigators determined that human umbilical cord MSC-derived exosomes reduced the deleterious effects of neurotoxic astrocytes in vitro and in vivo.
[Stem Cell Research & Therapy] |
|
|
|
| The authors preconditioned human amniotic MSCs under serum-containing and serum-free medium for 48 hours and compared the biological signatures and biofunctions from the view of cell morphology, immunophenotypes, and multi-lineage differentiation in vitro.
[Stem Cell Research & Therapy] |
|
|
|
| Public cord blood banks are required to measure cord blood units potency before their release, thus researchers developed a rapid flow cytometry assay based on the measurement of STAT-5 phosphorylation of CD34+ stem cells in response to IL-3 stimulation.
[International Journal of Laboratory Hematology] |
|
|
|
| Scientists investigated the effect of exosomes secreted by human umbilical cord MSC on aerobic metabolism of cobalt chloride-induced oxidative damage in the human retinal pigment epithelial cell line.
[International Ophthalmology] |
|
|
|
|
| Identifying the role of a disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) in normal pregnancy and preeclampsia has led to a better understanding of the underlying molecular and vascular pathways, and advanced the potential for novel biomarkers.
[Biochemical Pharmacology] |
|
|
|
|
| Through a selective granting process, Children’s Cancer Research Fund (CCRF) recently awarded these eight promising scientists the Emerging Scientist Award, each worth $100,000, to pursue their research.
[Children’s Cancer Research Fund] |
|
|
|
|
| December 10 – 14, 2022
Maui, Hawaii, United States |
|
|
|
|
|
| | Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| | UT Southwestern Medical Center – Dallas, Texas, United States |
|
|
|
| | St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| | The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| | Harvard Stem Cell Institute – Boston, Massachusetts, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
